![Edgar Engleman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edgar Engleman
Gründer bei
Vivo Capital LLC
Profil
Edgar G.
Engleman is the founder of Tranquis Therapeutics, Inc. (2016), Genelabs Technologies, Inc. (1984), Dendreon Corp.
(1992), CellGate Technologies LLC (1998), Cellgate, Inc. (1998), Neuraltus Pharmaceuticals, Inc. (2004), Medeor Therapeutics, Inc. (2013), Cetus Immune (1980), Dendreon Pharmaceuticals LLC (1992), Vivo Capital LLC (1996), and Bolt Biotherapeutics, Inc. (2015).
Titles held at Vivo Capital LLC include Managing Partner & Chief Scientific Advisor.
Titles held at Bolt Biotherapeutics, Inc. included Independent Director.
Dr. Engleman is also the founder of Neurocea LLC..
Dr. Engleman is currently Director at Semnur, Inc., Director-Immunology & Immunotherapy Program at Stanford Cancer Institute, Director at Ossium Health, Inc., and Professor at Stanford University School of Medicine since 1990.
Former positions include Director at Insmed, Inc., Pepgen Corp., Prestwick Pharmaceuticals, Inc., Naryx Pharma, Inc., Eiger BioPharmaceuticals, Inc., Nuveta, Inc., Gryphon Therapeutics, Inc., and Intermun, Inc.; Director at Soleno Therapeutics, Inc. from 2001 to 2017; Independent Director at REGENXBIO, Inc. from 2015 to 2016; Independent Director at Eiger BioPharmaceuticals, Inc. from 2016 to 2017.
Education includes undergraduate studies at Harvard University and Harvard College, and a doctorate from Columbia University College of Physicians & Surgeons.
Aktive Positionen von Edgar Engleman
| Unternehmen | Position | Beginn |
|---|---|---|
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle-market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life sciences. It provides financing for early stage, growth stage, buyouts, spin-offs, and restructurings. The firm also acquires controlling interest. | Gründer | 01.01.1996 |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1990 |
Semnur, Inc.
 Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Direktor/Vorstandsmitglied | - |
Neurocea LLC
 Neurocea LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Gründer | - |
Vivo Co-Invest (S) LP | Direktor/Vorstandsmitglied | - |
Ossium Health, Inc.
 Ossium Health, Inc. BiotechnologyHealth Technology Develops first-of-its-kind solution for processing, banking and deploying bone marrow derived cell therapies | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Edgar Engleman
| Unternehmen | Position | Ende |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Gründer | 15.05.2024 |
| SOLENO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 31.12.2017 |
| EIGER BIOPHARMACEUTICALS | Direktor/Vorstandsmitglied | 18.09.2017 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Edgar Engleman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
30
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 30 |
|---|---|
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Health Technology |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle-market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life sciences. It provides financing for early stage, growth stage, buyouts, spin-offs, and restructurings. The firm also acquires controlling interest. | Finance |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Pepgen Corp.
 Pepgen Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes products for the prevention, treatment of autoimmune and viral disorders | Health Technology |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Health Technology |
Naryx Pharma, Inc.
 Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of chronic sinusitis | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
 Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Nuveta, Inc.
 Nuveta, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
Semnur, Inc.
Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CellGate Technologies LLC
 CellGate Technologies LLC Computer PeripheralsElectronic Technology Manufactures integrated wireless IP modem adapters and provides wireless services | Electronic Technology |
Cellgate, Inc.
 Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals products | Health Technology |
Gryphon Therapeutics, Inc.
 Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces protein therapeutics | Health Technology |
Neuraltus Pharmaceuticals, Inc.
 Neuraltus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes molecule therapeutics | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients | Health Technology |
Eiger BioPharmaceuticals, Inc.
 Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
Cetus Immune | |
Neurocea LLC
Neurocea LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Ossium Health, Inc.
Ossium Health, Inc. BiotechnologyHealth Technology Develops first-of-its-kind solution for processing, banking and deploying bone marrow derived cell therapies | Health Technology |
Dendreon Pharmaceuticals LLC
 Dendreon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets immunotherapies | Health Technology |
Tranquis Therapeutics, Inc.
 Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel immuno-therapeutics for neurological diseases | Health Technology |
Intermun, Inc.
 Intermun, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Vivo Co-Invest (S) LP |
